Metipranolol

Christina Flaxel; R. Samples John

doi:10.3109/15569529109052141

Metipranolol

Christina Flaxel, R. Samples John

Ophthalmology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Metipranolol (Optipranololr̀) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.

Original language	English (US)
Pages (from-to)	171-174
Number of pages	4
Journal	Cutaneous and Ocular Toxicology
Volume	10
Issue number	3
DOIs	https://doi.org/10.3109/15569529109052141
State	Published - 1991

ASJC Scopus subject areas

Toxicology

Access to Document

10.3109/15569529109052141

Cite this

@article{dc6a39c22fe0497a8a858cf8b2944290,

title = "Metipranolol",

abstract = "Metipranolol (Optipranolol{\`r}) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.",

author = "Christina Flaxel and John, {R. Samples}",

year = "1991",

doi = "10.3109/15569529109052141",

language = "English (US)",

volume = "10",

pages = "171--174",

journal = "Cutaneous and Ocular Toxicology",

issn = "1556-9527",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Metipranolol

AU - Flaxel, Christina

AU - John, R. Samples

PY - 1991

Y1 - 1991

N2 - Metipranolol (Optipranololr̀) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.

AB - Metipranolol (Optipranololr̀) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=84907040350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907040350&partnerID=8YFLogxK

U2 - 10.3109/15569529109052141

DO - 10.3109/15569529109052141

M3 - Article

AN - SCOPUS:84907040350

SN - 1556-9527

VL - 10

SP - 171

EP - 174

JO - Cutaneous and Ocular Toxicology

JF - Cutaneous and Ocular Toxicology

IS - 3

ER -

Metipranolol

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this